logo
       Login

Follow us on:


KeyStone’s Special Research Reports
Special in-depth research, surveys and analysis complied into focussed reports with specific stock recommendations. These 12-24 page reports include individual BUY/SELL recommendations from inside and outside our coverage universe, sector analysis, company comparisons, commentary, and more. Individual reports can be purchased below. Small-Cap Growth Stocks and Dividend Growth Stocks. Clients receive individual recommendations, use their own discount brokerage, and build portfolios using our focussed diversification strategy.
Small Cap Related Page
Please Note: All VIP Clients receive all “Special Reports” with their annual subscriptions for no additional cost. All annual Canadian Growth Stock Clients receive all “Canadian Growth Stock Related Special Reports” with their annual subscriptions for no additional cost. All annual Income Stock clients receive all “Income/Growth Stock Related Special Reports” with their annual subscriptions for no additional cost. All annual U.S. Growth Stock clients receive all “U.S. Growth Stock Related Special Reports” with their annual subscriptions for no additional cost. All annual TFSA clients receive all “TFSA Related Special Reports” with their annual subscriptions for no additional cost.
Jump to page:     1  | 2  | 3  | 4  |
Canadian Focus BUY Quarterly Report August 2015

This month we are publishing a Special Canadian Focus BUY QuarterlyReport.

thumb
Buy $0.00

Canadian Focus BUY Quarterly Report May 2015

This month we are publishing a Special Canadian Focus BUY Quarterly Report. The report updates what was a very successful start to 2015 for KeyStone’s Canadian Small-Cap Recommendations.
thumb
Buy $0.00

2015 Cash Rich/Debt Free, Profitable Canadian Micro to Mid-Cap Report

Starting with over 3,500 Canadian stocks, our research uncovers over 60 Small to-Micro Cap stocks – all profitable, cash rich (no debt) companies, many with between 10-100% of their market caps in cash. We drill down on each providing fundamental statistics and research notes from our management interviews and provide a select number of NEW BUY Reports. Flash Updates with current BUYS|SELL|HOLD ratings on all Cash Rich Stocks currently in coverage. New buy recommendations include 2 high growth software Small-Caps, one low-priced Micro-Cap and bonus notes on our recent Specialty Pharmaceutical selection which trades at a significant discount to its peers. The report has become an annual must read for growth and value investors and with 16 stocks receiving premium takeover bids it serves as an excellent source of potential takeover targets.Unique research you can find nowhere else. Last year’s Top Cash Rich recommendation Cipher Pharmaceuticals (CPH:TSX), has gained over 155% - do not miss out on this year’s recommendations.
thumb
Buy $0.00

KeyStone's Small-Cap Report - Focus BUY Quick Updates October 2014

In light of the recent market gyrations and correctional action, a quick update on a number of names in our Small-Cap Focus BUY Portfolio is in order. In our Quick Focus BUY Updates, we begin by highlighting 3-long-term historical stars in our portfolio. Next we take a look at 4 select potential buying opportunities that have presented themselves, for long-term investors, in the pull-back. We highlight two stocks which we currently recommend clients “stay the course” with or continue to HOLD.

thumb
Buy $0.00

2014 GARP Cash Rich Report

With the Standard & Poor’s 500, a broad gauge of North America stocks, hitting all-time highs on a daily basis, the markets appear both euphoric and nervous all at once. The former however, continues to rule the day.

Many investors are sitting on excellent gains, and with the Street wrongly selling individuals on a “traders mentality” (to the benefit of the financial industry alone), we do not blame individuals who nervously look at their portfolios on a daily basis despite the gains.

The bitter taste of the 2008 credit crash lingers, but we do see it fading. This contributes to our cautious stance. But we do see value in some very select situations and today, we update our Cash Rich Stocks from our Small-Cap Portfolio and add a couple new BUY recommendations.

thumb
Buy $0.00

Jump to page:    1 | 2 | 3 | 4 |
Please Note: All VIP Clients receive all “Special Reports” with their annual subscriptions for no additional cost. All annual Canadian Growth Stock Clients receive all “Canadian Growth Stock Related Special Reports” with their annual subscriptions for no additional cost. All annual Income Stock clients receive all “Income/Growth Stock Related Special Reports” with their annual subscriptions for no additional cost. All annual U.S. Growth Stock clients receive all “U.S. Growth Stock Related Special Reports” with their annual subscriptions for no additional cost. All annual TFSA clients receive all “TFSA Related Special Reports” with their annual subscriptions for no additional cost.